Published in Int J Clin Exp Pathol on March 30, 2008
CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis. Cancer Cell (2011) 2.01
Identification and characterization of Hoxa9 binding sites in hematopoietic cells. Blood (2011) 1.63
GSK-3 promotes conditional association of CREB and its coactivators with MEIS1 to facilitate HOX-mediated transcription and oncogenesis. Cancer Cell (2010) 1.57
miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia. Nat Commun (2012) 1.49
MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia. Exp Hematol (2010) 1.35
PBX3 is an important cofactor of HOXA9 in leukemogenesis. Blood (2012) 1.30
H2.0-like homeobox regulates early hematopoiesis and promotes acute myeloid leukemia. Cancer Cell (2012) 1.19
Effects of the NUP98-DDX10 oncogene on primary human CD34+ cells: role of a conserved helicase motif. Leukemia (2010) 1.10
Role of HOXA9 in leukemia: dysregulation, cofactors and essential targets. Oncogene (2015) 0.99
C/EBPα is an essential collaborator in Hoxa9/Meis1-mediated leukemogenesis. Proc Natl Acad Sci U S A (2014) 0.95
Disruption of HOX activity leads to cell death that can be enhanced by the interference of iron uptake in malignant B cells. Leukemia (2010) 0.92
To Be Specific or Not: The Critical Relationship Between Hox And TALE Proteins. Trends Genet (2016) 0.85
Implication of IRF4 aberrant gene expression in the acute leukemias of childhood. PLoS One (2013) 0.80
An insertional mutagenesis screen identifies genes that cooperate with Mll-AF9 in a murine leukemogenesis model. Blood (2012) 0.78
Two isoforms of HOXA9 function differently but work synergistically in human MLL-rearranged leukemia. Blood Cells Mol Dis (2012) 0.77
Transcriptome Profiling of Pediatric Core Binding Factor AML. PLoS One (2015) 0.77
HLX in AML: novel prognostic and therapeutic target. Oncotarget (2012) 0.75
Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (1999) 83.27
ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia (2004) 17.08
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet (2001) 13.79
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature (2006) 11.90
Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med (2004) 11.61
Hox genes in vertebrate development. Cell (1994) 9.27
MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol Cell (2002) 8.17
The roles of FLT3 in hematopoiesis and leukemia. Blood (2002) 6.14
Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J (1998) 5.21
Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene (2001) 4.70
Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet (2007) 4.54
Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. Genes Dev (2007) 4.07
Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Dev (2003) 4.00
Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev (1995) 3.81
HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell (2002) 3.70
Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization. Mol Cell Biol (2004) 3.62
Hox genes in hematopoiesis and leukemogenesis. Oncogene (2007) 3.55
Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias. Nat Genet (1996) 3.32
HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood (2005) 3.09
Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. Proc Natl Acad Sci U S A (1994) 3.08
Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay. Proc Natl Acad Sci U S A (2007) 2.91
CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity. Mol Cell Biol (1999) 2.82
Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia. Nat Genet (1996) 2.78
Overexpression of HOXA10 in murine hematopoietic cells perturbs both myeloid and lymphoid differentiation and leads to acute myeloid leukemia. Mol Cell Biol (1997) 2.61
AbdB-like Hox proteins stabilize DNA binding by the Meis1 homeodomain proteins. Mol Cell Biol (1997) 2.56
Hematopoietic, angiogenic and eye defects in Meis1 mutant animals. EMBO J (2004) 2.55
Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood (1997) 2.55
Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny. Exp Hematol (2002) 2.53
Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion. Blood (2002) 2.48
Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation. Blood (2003) 2.35
Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia. Leukemia (2002) 2.29
An Mll-dependent Hox program drives hematopoietic progenitor expansion. Curr Biol (2004) 2.10
HOXA9 forms triple complexes with PBX2 and MEIS1 in myeloid cells. Mol Cell Biol (1999) 2.06
Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells. Blood (2005) 2.06
Pediatric acute myeloid leukemia with NPM1 mutations is characterized by a gene expression profile with dysregulated HOX gene expression distinct from MLL-rearranged leukemias. Leukemia (2007) 2.04
HOX and non-HOX homeobox genes in leukemic hematopoiesis. Stem Cells (2002) 1.94
Hoxa9 influences the phenotype but not the incidence of Mll-AF9 fusion gene leukemia. Blood (2003) 1.93
Tumor suppressor p16INK4A regulates polycomb-mediated DNA hypermethylation in human mammary epithelial cells. J Biol Chem (2006) 1.93
Molecular genetics of human leukemias: new insights into therapy. Semin Hematol (2002) 1.91
Hox regulation of normal and leukemic hematopoietic stem cells. Curr Opin Hematol (2005) 1.84
Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9. Blood (2003) 1.84
Structure of HoxA9 and Pbx1 bound to DNA: Hox hexapeptide and DNA recognition anterior to posterior. Genes Dev (2003) 1.82
Ex vivo expansion of human hematopoietic stem cells by direct delivery of the HOXB4 homeoprotein. Nat Med (2003) 1.81
HoxA9-mediated immortalization of myeloid progenitors requires functional interactions with TALE cofactors Pbx and Meis. Oncogene (2000) 1.79
Dimerization of MLL fusion proteins immortalizes hematopoietic cells. Cancer Cell (2003) 1.79
Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression. Mol Cell Biol (2000) 1.79
The specificity of homeotic gene function. Bioessays (1995) 1.78
Paralogous mouse Hox genes, Hoxa9, Hoxb9, and Hoxd9, function together to control development of the mammary gland in response to pregnancy. Proc Natl Acad Sci U S A (1999) 1.77
Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1. Blood (2003) 1.70
Altered HOX and WNT7A expression in human lung cancer. Proc Natl Acad Sci U S A (2000) 1.69
c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells. Blood (2006) 1.64
Hoxb4-deficient mice undergo normal hematopoietic development but exhibit a mild proliferation defect in hematopoietic stem cells. Blood (2004) 1.58
Overexpression of HOXB3 in hematopoietic cells causes defective lymphoid development and progressive myeloproliferation. Immunity (1997) 1.56
A conserved non-homeodomain Hoxa9 isoform interacting with CBP is co-expressed with the 'typical' Hoxa9 protein during embryogenesis. Gene Expr Patterns (2004) 1.52
Homeobox A9 transcriptionally regulates the EphB4 receptor to modulate endothelial cell migration and tube formation. Circ Res (2004) 1.46
DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets. Mol Cancer (2007) 1.44
PBX proteins: much more than Hox cofactors. Int J Dev Biol (2008) 1.40
The role of HOX genes in malignant myeloid disease. Curr Opin Hematol (2007) 1.39
Loss of function of the homeobox gene Hoxa-9 perturbs early T-cell development and induces apoptosis in primitive thymocytes. Blood (1998) 1.38
Gene expression profiling of acute myeloid leukemia with translocation t(8;16)(p11;p13) and MYST3-CREBBP rearrangement reveals a distinctive signature with a specific pattern of HOX gene expression. Cancer Res (2006) 1.38
Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes. Mol Cell Biol (2006) 1.36
Meis1a suppresses differentiation by G-CSF and promotes proliferation by SCF: potential mechanisms of cooperativity with Hoxa9 in myeloid leukemia. Proc Natl Acad Sci U S A (2001) 1.36
The role of NUP98 gene fusions in hematologic malignancy. Leuk Lymphoma (2004) 1.33
Deregulated expression of HOXB4 enhances the primitive growth activity of human hematopoietic cells. Blood (2002) 1.30
The transcriptome of the leukemogenic homeoprotein HOXA9 in human hematopoietic cells. Blood (2003) 1.30
Expression profiles of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangements. Proc Natl Acad Sci U S A (2003) 1.26
The HOX homeodomain proteins block CBP histone acetyltransferase activity. Mol Cell Biol (2001) 1.24
MEIS and PBX homeobox proteins in ovarian cancer. Eur J Cancer (2007) 1.19
A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias. Leukemia (2005) 1.18
MEIS1 and HOXA7 genes in human acute myeloid leukemia. Leuk Res (2000) 1.18
Continuous MLL-ENL expression is necessary to establish a "Hox Code" and maintain immortalization of hematopoietic progenitor cells. Cancer Res (2005) 1.18
The histone methyltransferase MLL is an upstream regulator of endothelial-cell sprout formation. Blood (2006) 1.16
Eukaryotic translation initiation factor 4E activity is modulated by HOXA9 at multiple levels. Mol Cell Biol (2005) 1.16
Review: genetic models of acute myeloid leukaemia. Oncogene (2008) 1.14
The Flt3 receptor tyrosine kinase collaborates with NUP98-HOX fusions in acute myeloid leukemia. Blood (2006) 1.14
Novel epigenetically deregulated genes in testicular cancer include homeobox genes and SCGB3A1 (HIN-1). J Pathol (2006) 1.10
HOXA9 activates transcription of the gene encoding gp91Phox during myeloid differentiation. J Biol Chem (2005) 1.10
Aberrant expression of HOXA9, DEK, CBL and CSF1R in acute myeloid leukemia. Leuk Lymphoma (2003) 1.07
Activation of stem-cell specific genes by HOXA9 and HOXA10 homeodomain proteins in CD34+ human cord blood cells. Stem Cells (2005) 1.04
HOXA10 is a critical regulator for hematopoietic stem cells and erythroid/megakaryocyte development. Blood (2007) 1.02
Molecular pathogenesis of MLL-associated leukemias. Int J Hematol (2005) 1.01
The MLL gene and translocations involving chromosomal band 11q23 in acute leukemia. Anticancer Res (2005) 1.00
HoxA9 induces insulin-like growth factor-1 receptor expression in B-lineage acute lymphoblastic leukemia. Leukemia (2008) 0.99
Analysis of HSC activity and compensatory Hox gene expression profile in Hoxb cluster mutant fetal liver cells. Blood (2005) 0.98
HOXA9 participates in the transcriptional activation of E-selectin in endothelial cells. Mol Cell Biol (2007) 0.98
Molecular dissection of Meis1 reveals 2 domains required for leukemia induction and a key role for Hoxa gene activation. Blood (2006) 0.95
Transplantable cell lines generated with NUP98-Hox fusion genes undergo leukemic progression by Meis1 independent of its binding to DNA. Leukemia (2005) 0.95
Flt3 is dispensable to the Hoxa9/Meis1 leukemogenic cooperation. Blood (2007) 0.94
Mixed lineage leukemia translocations and a leukemia stem cell program. Cancer Res (2007) 0.92
HOX-A10 regulates hematopoietic lineage commitment: evidence for a monocyte-specific transcription factor. Blood (2002) 0.91
Identification of a molecular signature for leukemic promyelocytes and their normal counterparts: Focus on DNA repair genes. Leukemia (2006) 0.90
Acute myeloid leukemia subgroups identified by pathway-restricted gene expression signatures. Acta Haematol (2006) 0.88
Meis1-mediated apoptosis is caspase dependent and can be suppressed by coexpression of HoxA9 in murine and human cell lines. Blood (2004) 0.84
Pediatric Acute Lymphoblastic Leukemia: Challenges and Controversies in 2000. Hematology Am Soc Hematol Educ Program (2000) 0.83
T cell receptor genotyping and HOXA/TLX1 expression define three T lymphoblastic lymphoma subsets which might affect clinical outcome. Clin Cancer Res (2008) 0.81
Three-dimensional intricacies in protein-DNA recognition and transcriptional control. Nat Struct Mol Biol (2007) 0.81
Hoxb3 deficiency impairs B lymphopoiesis in mouse bone marrow. Exp Hematol (2007) 0.79
MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol Cell (2002) 8.17
Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF. Cell (2005) 6.12
Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Mol Cell (2004) 6.08
Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization. Mol Cell Biol (2004) 3.62
A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification. Blood (2007) 3.60
Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc Natl Acad Sci U S A (2005) 3.37
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia. Nat Chem Biol (2012) 3.15
Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia. PLoS Genet (2012) 2.94
MLL associates specifically with a subset of transcriptionally active target genes. Proc Natl Acad Sci U S A (2005) 2.87
The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis. Cancer Cell (2010) 2.50
Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications. Cancer Res (2005) 2.45
CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis. Cancer Cell (2011) 2.01
Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation. Blood (2011) 1.99
The pathogenesis of mixed-lineage leukemia. Annu Rev Pathol (2011) 1.95
Loss-of-function Additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia. Blood (2009) 1.90
Interaction of MLL amino terminal sequences with menin is required for transformation. Cancer Res (2007) 1.82
Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease. EMBO J (2005) 1.79
Dimerization of MLL fusion proteins immortalizes hematopoietic cells. Cancer Cell (2003) 1.79
The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression. Proc Natl Acad Sci U S A (2006) 1.67
The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin. Oncogene (2005) 1.64
Identification and characterization of Hoxa9 binding sites in hematopoietic cells. Blood (2011) 1.63
Murine gammaherpesvirus 68 infection is associated with lymphoproliferative disease and lymphoma in BALB beta2 microglobulin-deficient mice. J Virol (2005) 1.46
The advent of targeted therapeutics and implications for pathologists. Am J Clin Pathol (2002) 1.38
MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia. Exp Hematol (2010) 1.35
MLL associates with telomeres and regulates telomeric repeat-containing RNA transcription. Mol Cell Biol (2009) 1.33
Mechanisms of transcriptional regulation by MLL and its disruption in acute leukemia. Int J Hematol (2007) 1.26
The PHD fingers of MLL block MLL fusion protein-mediated transformation. Blood (2008) 1.18
Chromatin immunoprecipitation (ChIP) for analysis of histone modifications and chromatin-associated proteins. Methods Mol Biol (2009) 1.13
Effects of the proteasome inhibitor PS-341 on tumor growth in HTLV-1 Tax transgenic mice and Tax tumor transplants. Blood (2004) 1.09
ECSASB2 mediates MLL degradation during hematopoietic differentiation. Blood (2011) 0.99
MLL core components give the green light to histone methylation. ACS Chem Biol (2006) 0.99
Acute myeloid leukemia diagnosis in the 21st century. Arch Pathol Lab Med (2010) 0.90
PAFc, a key player in MLL-rearranged leukemogenesis. Oncotarget (2010) 0.89
A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity. J Biol Chem (2012) 0.89
MLL-ENL inhibits polycomb repressive complex 1 to achieve efficient transformation of hematopoietic cells. Cell Rep (2013) 0.86
Targeting recruitment of disruptor of telomeric silencing 1-like (DOT1L): characterizing the interactions between DOT1L and mixed lineage leukemia (MLL) fusion proteins. J Biol Chem (2013) 0.83
Epigenetic dysregulation in cancer. Am J Pathol (2009) 0.82
The role of menin in hematopoiesis. Adv Exp Med Biol (2009) 0.82
The Cancer Genome Anatomy Project: power tools for cancer biologists. Cancer Invest (2003) 0.80
MLL fusion protein-driven AML is selectively inhibited by targeted disruption of the MLL-PAFc interaction. Blood (2013) 0.79
Significance of AF4-MLL reciprocal fusion in t(4;11) leukemias? Leuk Res (2010) 0.77
Deregulation of the HOXA9/MEIS1 axis in acute leukemia. Curr Opin Hematol (2016) 0.76
MLL-AF9 leukemia stem cells: hardwired or taking cues from the microenvironment? Cancer Cell (2008) 0.76
Structural basis of multimer-mediated mayhem. Cancer Cell (2006) 0.75
FUS (16p11) gene rearrangement as detected by fluorescence in-situ hybridization in cutaneous low-grade fibromyxoid sarcoma: a potential diagnostic tool. Am J Dermatopathol (2011) 0.75
Twenty-first century pathology sign-out. Clin Lab Med (2012) 0.75